Article info
Original research
Efficacy of chemotherapy according to BRCA status in patients with high-grade serous ovarian carcinoma at first platinum-sensitive relapse
- Correspondence to Dr Manuel Rodrigues, Institut Curie, Paris, 75005, France; manuel.rodrigues{at}curie.fr
Citation
Efficacy of chemotherapy according to BRCA status in patients with high-grade serous ovarian carcinoma at first platinum-sensitive relapse
Publication history
- Received September 20, 2022
- Accepted December 28, 2022
- First published January 11, 2023.
Article Versions
- View the most recent version of this article
- You are currently viewing a Previous version of this article (27 April 2023).
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ.